ArticleEthiopian journal of health sciences2025
Prevalence, Risk Factors, and Disease Progression of Severe Pneumonia in a Tertiary Hospital in Ethiopia.
Article in Ethiopian journal of health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Pneumonia remains the leading cause of mortality and morbidity among pediatric age groups worldwide. Several risk factors contribute to the progression of pneumonia into severe and complicated forms. Parapneumonic effusion is one of the most common complications to consider when severe pneumonia advances to a more critical stage. This study evaluates the prevalence, risk factors, and disease progression of severe pneumonia in children, providing valuable insights for resource-limited settings. Methods: A hospital-based prospective cohort study was conducted at a tertiary center from July 2022 to December 2023 among children aged 2 months to 14 years with severe pneumonia. Data were collected on socio-demographic characteristics, clinical status, disease progression, microbiological findings, and patient outcomes, and were analyzed using Stata Version 14. Results: A total of 74.13% of severe pneumonia cases occurred in children under 5 years of age. Fever, cough, tachypnea, dyspnea, and chest indrawing were the most frequently observed clinical presentations. Overall, 31.46% of patients progressed to parapneumonic effusion. Absence of prior pneumonia (AOR = 0.25; 95% CI: 0.11-0.57), no prior hospitalization for the current diagnosis (AOR = 0.49; 95% CI: 0.28-0.86), no exposure to secondhand cigarette smoke (AOR 0.24; 95% CI: 0.07-0.84), and no contact with a coughing patient (AOR = 0.53; 95% CI: 0.29-0.96) were each associated with lower odds of progression to parapneumonic effusion. In contrast, malnutrition was associated with higher odds of progression (AOR = 2.00; 95% CI: 1.18-3.54). Conclusion: A higher prevalence of severe pneumonia was observed in children under 5 years of age. Disease progression to parapneumonic effusion occurred in 31.46% of cases, and the mortality rate was 4.54%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.